Epigenetics Around the Web: Alzheimer’s drug moves closer to patients

| January 20, 2017
Screen Shot at AM
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

“Today, when we don’t know what causes a disease, we say it’s likely epigenetic. With this point of view, we get things wrong sometimes, which leads to some misconceptions. In a sense, I think this epigenetic viewpoint is right, but we need much more evidence to get a defined picture.”

Howard Cedar researcher at Hebrew University on current state of epigenetics

Epigenetics Around the Web is a weekly roundup of the latest studies and news in the field of epigenetics presented by GLP sister site the Epigenetics Literacy Project. This week features an interview with the scientist who discovered methylation’s job and an epigenetics-based Alzheimer’s disease drug.

Alzheimer’s drug

In 2016, ORY-2001, the first epigenetics-based drug for any neurodegenerative disease, began and successfully completed a Phase 1 clinical trial in Spain. The drug is a highly selective molecule that targets a histone demethylating enzyme called LSD1 and inhibits its activity. In mouse studies, treated subjects had marked improvements in cognition. In 2017, according to the Alzheimer’s Drug Discovery Foundation, the drug will begin a Phase 2 clinical trial. The drug also is being investigated as a possible treatment for multiple sclerosis and is in the early stages of a clinical trial for acute myeloid leukemia.

Methylation Maestro

Howard Cedar

Writer Anna Azvolinsky over at The Scientist has a great profile of Howard Cedar, one of the scientists who is credited with discovering that DNA methylation represses transcription. The story follows Cedar from a physics major at MIT to his current post as a faculty member at Hebrew University in Jerusalem, Israel. His early work at the National Institutes of Health was on chromatin structure and how it interacts with RNA polymerase. In the late 1970s, Cedar teamed up with fellow professor Aharon Razin and the two began uncovering the how and why of methylation. Methylation is the process by which a methyl group (a small molecule) is added directly to the DNA and it has a really interesting story. It’s presence throughout the genome was well established since the 1940s but what it was doing wouldn’t be uncovered by Cedar three decades later. Even after it’s role in gene repression was uncovered, it would take another three decades for scientists to take a strong interest in the process’s role in human health. Today many of the epigenetic studies investigate changes in methylation patterns on specific genes or areas of the genome. Today, Cedar is doing some of that work too — his lab investigates the role of methylation in B cells. The Scientist lists his ‘Greatest Hits’:

  • Demonstrated, with Richard Axel and Gary Felsenfeld, that chromatin can restrict transcription by globally blocking most of the genome while allowing access to specific genes
  • Along with Aharon Razin, showed that methylated DNA is stably propagated to daughter cells following mitotic cell division, and outlined the mechanism by which methylation sites are maintained through cell division
  • Was first to demonstrate that DNA methylation inhibits transcription and that undermethylated DNA is associated with actively transcribed genes
  • Provided some of the first evidence for epigenetic reprogramming by proving that methylation patterns are erased in the early embryo
  • Discovered the molecular rules involved in establishing DNA methylation patterns during development

 Epigenetics and the Holocaust

One of the areas of epigenetics that has caught the attention of the public is the idea (supported by some evidence) that stress from horrific events, such as the Holocaust and the Dutch Hunger Winter, may induce heritable epigenetic changes. Allison Bernstein, a neuroscientist who studies epigenetics in the brain, wrote an excellent article about this for GLP here. Researcher Ivan Rektor is studying this question at the Central European Institute of Technology of Masaryk University in Brno, Czech Republic. On January 12, he explained the work ongoing in his lab in an interview with Radio Prague:

We are interested in the transfer of the consequences of the horrible experience to the second and third generation, i.e. to the offspring of Holocaust survivors. It has been well-known that the children of Holocaust survivors may suffer –and sometimes suffer – from “Holocaust survivor children’s syndrome”’. They are more sensitive to stress, can suffer from emotional misbalance, are more prone to post-traumatic stress disorders and so on. This is well-known, but what is not clear is whether this transfer to the second generation is a social/behavioural transfer or a biological, genetic, epigenetic transfer. We are studying this question.

You can listen to the whole interview and read the transcript here.

Nicholas Staropoli is the director of the Epigenetics Literacy ProjectHe has an M.A. in biology from DePaul University and a B.S. in biomedical sciences from Marist College. Follow him on Twitter @NickfrmBoston.

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
a a b b a f ac a

Video: Death by COVID: The projected grim toll in historical context

The latest statistics, as of July 10, show COVID-19-related deaths in U.S. are just under 1,000 per day nationally, which is ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
types of oak trees

Infographic: Power of evolution? How oak trees came to dominate North American forests

Over the course of some 56 million years, oaks, which all belong to the genus Quercus, evolved from a single undifferentiated ...
biotechnology worker x

Can GMOs rescue threatened plants and crops?

Some scientists and ecologists argue that humans are in the midst of an "extinction crisis" — the sixth wave of ...
food globe x

Are GMOs necessary to feed the world?

Experts estimate that agricultural production needs to roughly double in the coming decades. How can that be achieved? ...
eating gmo corn on the cob x

Are GMOs safe?

In 2015, 15 scientists and activists issued a statement, "No Scientific consensus on GMO safety," in the journal Environmental Sciences ...
Screen Shot at PM

Charles Benbrook: Agricultural economist and consultant for the organic industry and anti-biotechnology advocacy groups

Independent scientists rip Benbrook's co-authored commentary in New England Journal calling for reassessment of dangers of all GMO crops and herbicides ...
Screen Shot at PM

ETC Group: ‘Extreme’ biotechnology critic campaigns against synthetic biology and other forms of ‘extreme genetic engineering’

The ETC Group is an international environmental non-governmental organization (NGO) based in Canada whose stated purpose is to monitor "the impact of emerging technologies and ...
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend